Fucose-Functionalized Precision Glycomacromolecules Targeting Human Norovirus Capsid Protein

Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus’s biophysical properties and biochemical function with the aim of deriving novel and highly potent entry inhibitors to prevent infection. Recently, it...

Full description

Saved in:
Bibliographic Details
Published inBiomacromolecules Vol. 19; no. 9; pp. 3714 - 3724
Main Authors Bücher, Katharina Susanne, Yan, Hao, Creutznacher, Robert, Ruoff, Kerstin, Mallagaray, Alvaro, Grafmüller, Andrea, Dirks, Jan Sebastian, Kilic, Turgay, Weickert, Sabrina, Rubailo, Anna, Drescher, Malte, Schmidt, Stephan, Hansman, Grant, Peters, Thomas, Uetrecht, Charlotte, Hartmann, Laura
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 10.09.2018
Subjects
Online AccessGet full text
ISSN1525-7797
1526-4602
1526-4602
DOI10.1021/acs.biomac.8b00829

Cover

Abstract Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus’s biophysical properties and biochemical function with the aim of deriving novel and highly potent entry inhibitors to prevent infection. Recently, it has been shown that the protruding P domain dimer (P-dimer) of a GII.10 Norovirus strain exhibits two new binding sites for l-fucose in addition to the canonical binding sites. Thus, these sites provide a novel target for the design of multivalent fucose ligands as entry inhibitors of norovirus infections. In this current study, a first generation of multivalent fucose-functionalized glycomacromolecules was synthesized and applied as model structures to investigate the potential targeting of fucose binding sites in human norovirus P-dimer. Following previously established solid phase polymer synthesis, eight precision glycomacromolecules varying in number and position of fucose ligands along an oligo­(amidoamine) backbone were obtained and then used in a series of binding studies applying native MS, NMR, and X-ray crystallography. We observed only one fucose per glycomacromolecule binding to one P-dimer resulting in similar binding affinities for all fucose-functionalized glycomacromolecules, which based on our current findings we attribute to the overall size of macromolecular ligands and possibly to steric hindrance.
AbstractList Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus's biophysical properties and biochemical function with the aim of deriving novel and highly potent entry inhibitors to prevent infection. Recently, it has been shown that the protruding P domain dimer (P-dimer) of a GII.10 Norovirus strain exhibits two new binding sites for l-fucose in addition to the canonical binding sites. Thus, these sites provide a novel target for the design of multivalent fucose ligands as entry inhibitors of norovirus infections. In this current study, a first generation of multivalent fucose-functionalized glycomacromolecules was synthesized and applied as model structures to investigate the potential targeting of fucose binding sites in human norovirus P-dimer. Following previously established solid phase polymer synthesis, eight precision glycomacromolecules varying in number and position of fucose ligands along an oligo(amidoamine) backbone were obtained and then used in a series of binding studies applying native MS, NMR, and X-ray crystallography. We observed only one fucose per glycomacromolecule binding to one P-dimer resulting in similar binding affinities for all fucose-functionalized glycomacromolecules, which based on our current findings we attribute to the overall size of macromolecular ligands and possibly to steric hindrance.Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus's biophysical properties and biochemical function with the aim of deriving novel and highly potent entry inhibitors to prevent infection. Recently, it has been shown that the protruding P domain dimer (P-dimer) of a GII.10 Norovirus strain exhibits two new binding sites for l-fucose in addition to the canonical binding sites. Thus, these sites provide a novel target for the design of multivalent fucose ligands as entry inhibitors of norovirus infections. In this current study, a first generation of multivalent fucose-functionalized glycomacromolecules was synthesized and applied as model structures to investigate the potential targeting of fucose binding sites in human norovirus P-dimer. Following previously established solid phase polymer synthesis, eight precision glycomacromolecules varying in number and position of fucose ligands along an oligo(amidoamine) backbone were obtained and then used in a series of binding studies applying native MS, NMR, and X-ray crystallography. We observed only one fucose per glycomacromolecule binding to one P-dimer resulting in similar binding affinities for all fucose-functionalized glycomacromolecules, which based on our current findings we attribute to the overall size of macromolecular ligands and possibly to steric hindrance.
Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus’s biophysical properties and biochemical function with the aim of deriving novel and highly potent entry inhibitors to prevent infection. Recently, it has been shown that the protruding P domain dimer (P-dimer) of a GII.10 Norovirus strain exhibits two new binding sites for l-fucose in addition to the canonical binding sites. Thus, these sites provide a novel target for the design of multivalent fucose ligands as entry inhibitors of norovirus infections. In this current study, a first generation of multivalent fucose-functionalized glycomacromolecules was synthesized and applied as model structures to investigate the potential targeting of fucose binding sites in human norovirus P-dimer. Following previously established solid phase polymer synthesis, eight precision glycomacromolecules varying in number and position of fucose ligands along an oligo(amidoamine) backbone were obtained and then used in a series of binding studies applying native MS, NMR, and X-ray crystallography. We observed only one fucose per glycomacromolecule binding to one P-dimer resulting in similar binding affinities for all fucose-functionalized glycomacromolecules, which based on our current findings we attribute to the overall size of macromolecular ligands and possibly to steric hindrance.
Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus’s biophysical properties and biochemical function with the aim of deriving novel and highly potent entry inhibitors to prevent infection. Recently, it has been shown that the protruding P domain dimer (P-dimer) of a GII.10 Norovirus strain exhibits two new binding sites for l-fucose in addition to the canonical binding sites. Thus, these sites provide a novel target for the design of multivalent fucose ligands as entry inhibitors of norovirus infections. In this current study, a first generation of multivalent fucose-functionalized glycomacromolecules was synthesized and applied as model structures to investigate the potential targeting of fucose binding sites in human norovirus P-dimer. Following previously established solid phase polymer synthesis, eight precision glycomacromolecules varying in number and position of fucose ligands along an oligo­(amidoamine) backbone were obtained and then used in a series of binding studies applying native MS, NMR, and X-ray crystallography. We observed only one fucose per glycomacromolecule binding to one P-dimer resulting in similar binding affinities for all fucose-functionalized glycomacromolecules, which based on our current findings we attribute to the overall size of macromolecular ligands and possibly to steric hindrance.
Author Kilic, Turgay
Grafmüller, Andrea
Creutznacher, Robert
Bücher, Katharina Susanne
Drescher, Malte
Uetrecht, Charlotte
Yan, Hao
Hartmann, Laura
Peters, Thomas
Mallagaray, Alvaro
Weickert, Sabrina
Schmidt, Stephan
Ruoff, Kerstin
Dirks, Jan Sebastian
Rubailo, Anna
Hansman, Grant
AuthorAffiliation Heinrich-Heine-University Düsseldorf
University of Konstanz
European XFEL GmbH
University of Heidelberg
Institute for Organic Chemistry and Macromolecular Chemistry
Institute of Chemistry and Metabolomics
Max-Planck-Institute of Colloids and Interfaces
Department of Theory and Bio-Systems
Department of Chemistry and Konstanz Research School Chemical Biology
Heinrich Pette Institute
Schaller Research Group at the University of Heidelberg and the DKFZ, Heidelberg, Germany and Department of Infectious Diseases, Virology
AuthorAffiliation_xml – name: Max-Planck-Institute of Colloids and Interfaces
– name: Institute for Organic Chemistry and Macromolecular Chemistry
– name: Schaller Research Group at the University of Heidelberg and the DKFZ, Heidelberg, Germany and Department of Infectious Diseases, Virology
– name: University of Heidelberg
– name: Department of Chemistry and Konstanz Research School Chemical Biology
– name: Department of Theory and Bio-Systems
– name: Heinrich-Heine-University Düsseldorf
– name: Institute of Chemistry and Metabolomics
– name: European XFEL GmbH
– name: Heinrich Pette Institute
– name: University of Konstanz
Author_xml – sequence: 1
  givenname: Katharina Susanne
  surname: Bücher
  fullname: Bücher, Katharina Susanne
  organization: Institute for Organic Chemistry and Macromolecular Chemistry
– sequence: 2
  givenname: Hao
  surname: Yan
  fullname: Yan, Hao
  organization: Heinrich Pette Institute
– sequence: 3
  givenname: Robert
  surname: Creutznacher
  fullname: Creutznacher, Robert
  organization: Institute of Chemistry and Metabolomics
– sequence: 4
  givenname: Kerstin
  surname: Ruoff
  fullname: Ruoff, Kerstin
  organization: University of Heidelberg
– sequence: 5
  givenname: Alvaro
  surname: Mallagaray
  fullname: Mallagaray, Alvaro
  organization: Institute of Chemistry and Metabolomics
– sequence: 6
  givenname: Andrea
  orcidid: 0000-0002-1671-3158
  surname: Grafmüller
  fullname: Grafmüller, Andrea
  organization: Department of Theory and Bio-Systems
– sequence: 7
  givenname: Jan Sebastian
  surname: Dirks
  fullname: Dirks, Jan Sebastian
  organization: Institute for Organic Chemistry and Macromolecular Chemistry
– sequence: 8
  givenname: Turgay
  surname: Kilic
  fullname: Kilic, Turgay
  organization: University of Heidelberg
– sequence: 9
  givenname: Sabrina
  orcidid: 0000-0002-5339-2779
  surname: Weickert
  fullname: Weickert, Sabrina
  organization: Department of Chemistry and Konstanz Research School Chemical Biology
– sequence: 10
  givenname: Anna
  surname: Rubailo
  fullname: Rubailo, Anna
  organization: Department of Chemistry and Konstanz Research School Chemical Biology
– sequence: 11
  givenname: Malte
  orcidid: 0000-0002-3571-3452
  surname: Drescher
  fullname: Drescher, Malte
  organization: Department of Chemistry and Konstanz Research School Chemical Biology
– sequence: 12
  givenname: Stephan
  orcidid: 0000-0002-4357-304X
  surname: Schmidt
  fullname: Schmidt, Stephan
  organization: Institute for Organic Chemistry and Macromolecular Chemistry
– sequence: 13
  givenname: Grant
  surname: Hansman
  fullname: Hansman, Grant
  organization: University of Heidelberg
– sequence: 14
  givenname: Thomas
  surname: Peters
  fullname: Peters, Thomas
  organization: Institute of Chemistry and Metabolomics
– sequence: 15
  givenname: Charlotte
  surname: Uetrecht
  fullname: Uetrecht, Charlotte
  email: charlotte.uetrecht@xfel.eu
  organization: European XFEL GmbH
– sequence: 16
  givenname: Laura
  orcidid: 0000-0003-0115-6405
  surname: Hartmann
  fullname: Hartmann, Laura
  email: laura.hartmann@hhu.de
  organization: Institute for Organic Chemistry and Macromolecular Chemistry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30071731$$D View this record in MEDLINE/PubMed
BookMark eNqNkU9PwyAYh4nR6PzzBTyYHr10vkBL6dEsTk0W9aA3E0LZ2wXTlgnFRD-9rZsXD4snIPyel_B7jsl-5zok5JzClAKjV9qEaWVdq81UVgCSlXtkQnMm0kwA2__Z52lRlMUROQ7hDQBKnuWH5IgDFLTgdEJe59G4gOk8dqa3rtON_cJl8uTR2DCck9vm04xPeNe6Bk1sMCTP2q-wt90quYut7pIH592H9TEkM70OdsRdj7Y7JQe1bgKebdcT8jK_eZ7dpYvH2_vZ9SLVGS37VABUsi5ZWRgJFEWd4xLqPOeMVQwyJsUSS8mrkmleU2l4IbJaw_BnqnNTC35CLjdz1969Rwy9am0w2DS6QxeDYpRTKTKW_SMKkhdMSMmH6MU2GqsWl2rtbav9p_otbwjITWAoJwSPtTK212OLvde2URTU6EkNntTGk9p6GlD2B_2dvhOabqDx7s1FP9gKu4BvV2-pHg
CitedBy_id crossref_primary_10_1039_C9RA05497A
crossref_primary_10_1002_mabi_201800426
crossref_primary_10_1002_mas_21721
crossref_primary_10_1002_mabi_201900033
crossref_primary_10_1016_j_lwt_2023_114554
crossref_primary_10_3390_v13040668
crossref_primary_10_1002_mabi_202200358
crossref_primary_10_1021_jacs_9b13484
crossref_primary_10_1016_j_jbiotec_2020_05_001
crossref_primary_10_1039_C8CC04898C
crossref_primary_10_3390_molecules24061004
crossref_primary_10_1039_D2CS00983H
crossref_primary_10_1021_acsmaterialslett_1c00358
crossref_primary_10_1016_j_progpolymsci_2023_101677
crossref_primary_10_1039_D0SC03457F
crossref_primary_10_1002_mabi_201800337
crossref_primary_10_3390_md19110591
crossref_primary_10_1021_acs_biomac_2c00829
crossref_primary_10_3390_molecules26082125
crossref_primary_10_1002_macp_201900323
crossref_primary_10_1002_ejoc_201901128
crossref_primary_10_1016_j_eti_2024_103643
crossref_primary_10_1016_j_ejmech_2025_117450
crossref_primary_10_1042_BST20210526
crossref_primary_10_3390_life11060554
Cites_doi 10.1021/ja411582t
10.1007/s10719-017-9792-5
10.1016/j.pnmrs.2013.02.001
10.1021/ja072999x
10.1002/chem.201003432
10.1002/ange.201505672
10.1002/chem.201003414
10.1021/ja306053s
10.1002/psc.951
10.1002/rmv.704
10.1002/anie.201101074
10.1016/j.jmr.2011.08.035
10.1371/journal.pmed.0050031
10.1128/JVI.00246-11
10.1021/bm300331z
10.1021/acsmacrolett.7b00124
10.1093/glycob/cws141
10.1128/JVI.02968-14
10.1002/anie.200390233
10.1016/j.virol.2015.04.006
10.1021/ac0522005
10.1021/acs.biomac.6b01657
10.1016/0009-2614(84)80148-7
10.1002/mabi.201700198
10.1093/glycob/cwy028
10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.3.CO;2-H
10.1016/j.tetlet.2007.03.165
10.1146/annurev-physchem-032511-143716
10.1021/ac048433y
10.1039/c1pc90006d
10.1021/ja0100120
10.1021/cr500303t
10.1073/pnas.0803275105
10.1128/JVI.05909-11
10.1128/JVI.78.12.6233-6242.2004
10.1002/anie.201008120
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1021/acs.biomac.8b00829
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
AGRICOLA
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1526-4602
EndPage 3724
ExternalDocumentID 30071731
10_1021_acs_biomac_8b00829
a028469727
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
02
23N
53G
55A
5GY
7~N
AABXI
ABFLS
ABMVS
ABPTK
ABUCX
ACGFS
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
DU5
EBS
ED
ED~
EJD
F5P
GNL
IH9
JG
JG~
P2P
RNS
ROL
RSW
TN5
UI2
VF5
VG9
W1F
X
XKZ
---
-~X
4.4
5VS
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ADHLV
AHGAQ
BAANH
CITATION
CUPRZ
GGK
ZCA
~02
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-a419t-600b8f9297c801e6f5ed0f55322b204286de983b92a3f18c3764fa08b01a5cf63
IEDL.DBID ACS
ISSN 1525-7797
1526-4602
IngestDate Thu Jul 10 23:36:09 EDT 2025
Fri Jul 11 15:51:58 EDT 2025
Wed Feb 19 02:35:16 EST 2025
Tue Jul 01 04:07:57 EDT 2025
Thu Apr 24 22:53:39 EDT 2025
Thu Aug 27 13:42:24 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a419t-600b8f9297c801e6f5ed0f55322b204286de983b92a3f18c3764fa08b01a5cf63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-4357-304X
0000-0002-1671-3158
0000-0002-3571-3452
0000-0003-0115-6405
0000-0002-5339-2779
OpenAccessLink http://hdl.handle.net/10072/406720
PMID 30071731
PQID 2083726883
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2131864246
proquest_miscellaneous_2083726883
pubmed_primary_30071731
crossref_citationtrail_10_1021_acs_biomac_8b00829
crossref_primary_10_1021_acs_biomac_8b00829
acs_journals_10_1021_acs_biomac_8b00829
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
XKZ
7~N
VG9
W1F
ACS
AEESW
AFEFF
ABMVS
ABUCX
IH9
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-09-10
PublicationDateYYYYMMDD 2018-09-10
PublicationDate_xml – month: 09
  year: 2018
  text: 2018-09-10
  day: 10
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Biomacromolecules
PublicationTitleAlternate Biomacromolecules
PublicationYear 2018
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref6/cit6
ref36/cit36
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
ref32/cit32
ref23/cit23
ref14/cit14
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
ref34/cit34
ref37/cit37
ref28/cit28
ref20/cit20
ref17/cit17
ref10/cit10
ref26/cit26
ref35/cit35
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref22/cit22
ref13/cit13
ref33/cit33
ref4/cit4
ref30/cit30
ref1/cit1
ref24/cit24
ref7/cit7
References_xml – ident: ref12/cit12
  doi: 10.1021/ja411582t
– ident: ref6/cit6
  doi: 10.1007/s10719-017-9792-5
– ident: ref36/cit36
  doi: 10.1016/j.pnmrs.2013.02.001
– ident: ref17/cit17
  doi: 10.1021/ja072999x
– ident: ref11/cit11
  doi: 10.1002/chem.201003432
– ident: ref7/cit7
  doi: 10.1002/ange.201505672
– ident: ref10/cit10
  doi: 10.1002/chem.201003414
– ident: ref20/cit20
  doi: 10.1021/ja306053s
– ident: ref21/cit21
  doi: 10.1002/psc.951
– ident: ref4/cit4
  doi: 10.1002/rmv.704
– ident: ref32/cit32
  doi: 10.1007/s10719-017-9792-5
– ident: ref19/cit19
  doi: 10.1002/anie.201101074
– ident: ref28/cit28
  doi: 10.1016/j.jmr.2011.08.035
– ident: ref1/cit1
  doi: 10.1371/journal.pmed.0050031
– ident: ref8/cit8
  doi: 10.1128/JVI.00246-11
– ident: ref13/cit13
  doi: 10.1021/bm300331z
– ident: ref14/cit14
  doi: 10.1021/acsmacrolett.7b00124
– ident: ref22/cit22
  doi: 10.1093/glycob/cws141
– ident: ref37/cit37
  doi: 10.1128/JVI.02968-14
– ident: ref35/cit35
  doi: 10.1002/anie.200390233
– ident: ref5/cit5
  doi: 10.1016/j.virol.2015.04.006
– ident: ref24/cit24
  doi: 10.1021/ac0522005
– ident: ref15/cit15
  doi: 10.1021/acs.biomac.6b01657
– ident: ref29/cit29
  doi: 10.1016/0009-2614(84)80148-7
– ident: ref16/cit16
  doi: 10.1002/mabi.201700198
– ident: ref31/cit31
  doi: 10.1093/glycob/cwy028
– ident: ref34/cit34
  doi: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.3.CO;2-H
– ident: ref18/cit18
  doi: 10.1016/j.tetlet.2007.03.165
– ident: ref30/cit30
  doi: 10.1146/annurev-physchem-032511-143716
– ident: ref25/cit25
  doi: 10.1021/ac048433y
– ident: ref23/cit23
  doi: 10.1039/c1pc90006d
– ident: ref33/cit33
  doi: 10.1021/ja0100120
– ident: ref26/cit26
  doi: 10.1021/cr500303t
– ident: ref2/cit2
  doi: 10.1073/pnas.0803275105
– ident: ref9/cit9
  doi: 10.1128/JVI.05909-11
– ident: ref3/cit3
  doi: 10.1128/JVI.78.12.6233-6242.2004
– ident: ref27/cit27
  doi: 10.1002/anie.201008120
SSID ssj0009345
Score 2.4082077
Snippet Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus’s...
Norovirus infection is the major cause of nonbacterial gastroenteritis in humans and has been the subject of numerous studies investigating the virus's...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3714
SubjectTerms Antiviral Agents - chemical synthesis
Antiviral Agents - pharmacology
binding capacity
binding sites
Capsid Proteins - chemistry
Capsid Proteins - metabolism
coat proteins
fucose
Fucose - chemistry
gastroenteritis
humans
Ligands
Molecular Docking Simulation
Norovirus
Norovirus - drug effects
nuclear magnetic resonance spectroscopy
polymers
Protein Binding
viruses
X-ray diffraction
Title Fucose-Functionalized Precision Glycomacromolecules Targeting Human Norovirus Capsid Protein
URI http://dx.doi.org/10.1021/acs.biomac.8b00829
https://www.ncbi.nlm.nih.gov/pubmed/30071731
https://www.proquest.com/docview/2083726883
https://www.proquest.com/docview/2131864246
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwED_mfNAXvz_mFxUEH7Sz6UfaPsqwDmFDcIM9CCXJUhDHOtbuwf31XtJ2Irqx15JcyeVy97vkPgBuXNR4gqD2E4Jz0w1CanI8WCbKBwksKS1BVYJzp0vbffdl4A1qcL_kBd8mD0xkTZWKjuQDrlNBN2DTpmhoFBBqvf2U2HV0S2LV0AcxY-iXKTL_01DGSGS_jdEShKktTbQLnSpfpwgw-WzOct4U87_lG9daxB7slJDTeCxkZB9qcnwAW62q09shvEc6bN2M0MYVV4Mfczk0Xqdl_x3jefQlFFUVuqe76crM6OkQcjR8hn4HMLqpupyYzjKjxSYo4jg9VZ00j6AfPfVabbPsumAyl4S5iQiIBwmiJl-g9ZI08eTQSjwPTz63lYdFhzIMHB7azElIIFBDuQmzcFmEeSKhzjHUx-lYnoKB3pfjE8LQ5glXWiEX0kf_jnKGBFzmNOAWGROXpyaL9YO4TWL1seBWXHKrAaTaqFiUxctVD43Ryjl3izmTonTHytHX1f7HyH71bMLGMp1lsY0o1UeBC5wVYwjqRnTlXNqAk0J4Fv90ilAHcrb2as9hG3GZDksh1gXU8-lMXiL2yfmVFvlv93D_MA
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT8IwEL8oPuCL3x_4ORMTH8x03bpueyRERAViIiQ8mCxt6RIjAcLgQf56r92AaJToa9Ne1-56H-3d_QAuKUo8SVD6SSmETcOI2QIPlo38QUJHKUcyneDcaLJamz52_E6ex61zYfAjUqSUmkf8RXUBcqvbdEY6zhIKkxG6Cms-o0zjNZQrL4tKu55BJta4Pmg6RkGeKfMzDa2TZPpVJ_1iaBqFU92E1vxTTZzJ-81kLG7k9FsVx3-uZQs2cgPUKmccsw0rqr8DxcoM920XXqsmiN2uosbLLgrfpqprPY9yNB7rvvchNVUdyGewdVVqtUxAOapBy7wKWM2BvqoYTVKrwofI8Dh8oHE196BdvWtVanaOwWBzSqKxjfaQCBO0oQKJukyxxFddJ_F9lAPC1f4W66oo9ETkci8hoUR5RRPu4LII92XCvH0o9Ad9dQgW-mJeQAhHDSipciIhVYDeHhMcCVDuleAKNybOz1Aam-dxl8S6MdutON-tEpDZ_4plXspcI2r0lo65no8ZZoU8lva-mLFBjNuvH1F4Xw0maeyizRq4LAy9JX0ISkp07CgrwUHGQ_M5vSzwgRz9ebXnUKy1GvW4_tB8OoZ1tNhMwApxTqAwHk3UKVpFY3FmTsEn0U0HoQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZSwMxEB60gvrifdRzBcEH2brZI7v7WKprvUpBhT4IS5JmQSxt6bYP9tc7yaYVRYv4GnJsspOZL8nMfACnPmo8QVD7CcG57UcxtTluLBvlg0SOlI6gKsD5oUHrz_5tK2iZqwsVC4MfkWNPuX7EV7u6385MhgFyocpVVDqOFHEdFToPC4hIiOJsqNYeP7PtepqdWHH7IHyMQxMt83Mfyi6J_Ktd-gVsaqOTrEJr-rna1-StMhryihh_y-T4j_mswYoBola1kJx1mJPdDViqTfjfNuEl0c7sdoKWr7gwfB3LttUcGFYe67rzLlSvyqFPc-zK3HrSjuVoDi39OmA1eurKYjDKrRrro-Bj857i19yC5-TqqVa3DReDzXwSD23ERTzKEEuFAm2apFkg204WBKgPuKvOXbQt48jjscu8jEQC9ZafMQenRVggMuptQ6nb68pdsPBM5oWEMLSEwpdOzIUM8dRHOcMOfOaV4QwXJjV7KU_1M7lLUlVYrFZqVqsMZPLPUmFSmitmjc7MNufTNv0iocfM2icTUUhx-dVjCuvK3ihPXcSuoUujyJtRh6DGxAOeT8uwU8jRdEyvcIAge3-e7TEsNi-T9P6mcbcPywjctN8KcQ6gNByM5CGCoyE_0hvhAzYEChs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fucose-Functionalized+Precision+Glycomacromolecules+Targeting+Human+Norovirus+Capsid+Protein&rft.jtitle=Biomacromolecules&rft.au=B%C3%BCcher%2C+Katharina+Susanne&rft.au=Yan%2C+Hao&rft.au=Creutznacher%2C+Robert&rft.au=Ruoff%2C+Kerstin&rft.date=2018-09-10&rft.issn=1526-4602&rft.eissn=1526-4602&rft.volume=19&rft.issue=9&rft.spage=3714&rft_id=info:doi/10.1021%2Facs.biomac.8b00829&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-7797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-7797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-7797&client=summon